The Impact of the Entry of Biosimilars: Evidence from Europe

Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry, however only a few biosimilars have been approved in the US since 2015, thereby largely preserving biologics from competition. We analyze European markets, which have had biosimilar competition since 2006. Using our own survey, we analyze how market features and public policies predict biosimilar entry, price, and penetration, finding significant heterogeneity across countries and products. Effective buyer institutions are associated with increased biosimilar penetration. Our estimates can inform ongoing policy discussions.     

The stock market’s reaction to macroeconomic news under ambiguity

Financial Markets and Portfolio Management - We investigate the quality of the information that macroeconomic news conveys to the stock market about future business conditions. Our econometric...     

Translating Corporate Social Responsibility into Action: A Social Learning Perspective

Journal of Business Ethics - Interest in the microfoundations of corporate social responsibility (CSR) has grown over the past decade. In this study, we draw on social learning theory to examine...     

New-structuralist exchange-rate policy and the pattern of specialization in Latin American countries

The present article critically examines the transmission channels from real exchange rate undervaluation to output growth adduced by New-Structuralism (NS). To this end, we slightly modify new-structuralist canonical model for small open peripheral economies, and make the underlying productive structure depend on income distribution. This allows us both to discuss: (a) the limits of the transmission channels adduced by NS in their own terms, that is, under the assumption that the tradable sector is the modern sector; and (b) the further limitations of these channels when the pattern of trade is more suitable to characterize Latin American countries, whose tradable sector mainly exports primary goods under conditions of differential rent. We conclude that the channels work under highly restrictive assumptions, and therefore the alleged positive relationship between real exchange rate and growth cannot be generally ascertained.     

A Balancing Act: Work–Life Balance and Multiple Stakeholder Outcomes in Hospitals

This article examines the direct and indirect effects of work–life balance (WLB) practices on multiple stakeholder outcomes in hospitals. The authors examine the direct and indirect effects of WLB practices in 173 hospitals in the United Kingdom on organizational, patient care and employee outcomes. The article proposes a model in which the effects of WLB practices on patient care outcomes and financial performance are mediated by employee turnover intentions. The authors provide strong support for the potential vested in WLB practices in the healthcare setting. Results indicate that greater use of WLB practices enhances outcomes for hospitals, their employees and the patients they care for.     

Trade, production sharing, and the international transmission of business cycles

Countries that are more engaged in production sharing exhibit higher bilateral manufacturing output correlations. We use data on trade flows between US multinationals and their affiliates as well as trade between the United States and Mexican maquiladoras to measure production-sharing trade and its link with the business cycle. We then develop a quantitative model of international business cycles that generates a positive link between the extent of vertically integrated production-sharing trade and internationally synchronized business cycles. A key assumption in the model is a relatively low elasticity of substitution between home and foreign inputs in the production of the vertically integrated good.     

Regulated price reforms and unregulated substitutes: the case of residential piped gas in Argentina

This paper examines the impact of regulated piped gas price changes on connection decisions and households’ welfare. The analysis explicitly considers bottled gas as a substitute for piped gas and therefore uses a simple utility maximization model that yields both a gas-type choice model and a demand specification whose parameterization allows examining households’ responses to regulated price changes. The results show that relative gas prices and household features explain households’ piped gas usage. They also provide insights on the distribution of welfare changes. The findings illustrate the impact of tariff rebalancing and unregulated substitutes on further access to regulated network services.